1. Home
  2. ALLK vs SHFS Comparison

ALLK vs SHFS Comparison

Compare ALLK & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • SHFS
  • Stock Information
  • Founded
  • ALLK 2012
  • SHFS 2015
  • Country
  • ALLK United States
  • SHFS United States
  • Employees
  • ALLK N/A
  • SHFS N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • ALLK Health Care
  • SHFS Finance
  • Exchange
  • ALLK Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • ALLK 22.5M
  • SHFS 20.8M
  • IPO Year
  • ALLK 2018
  • SHFS N/A
  • Fundamental
  • Price
  • ALLK $0.29
  • SHFS $0.37
  • Analyst Decision
  • ALLK Hold
  • SHFS
  • Analyst Count
  • ALLK 3
  • SHFS 0
  • Target Price
  • ALLK $2.00
  • SHFS N/A
  • AVG Volume (30 Days)
  • ALLK 5.6M
  • SHFS 118.1K
  • Earning Date
  • ALLK 03-13-2025
  • SHFS 03-31-2025
  • Dividend Yield
  • ALLK N/A
  • SHFS N/A
  • EPS Growth
  • ALLK N/A
  • SHFS N/A
  • EPS
  • ALLK N/A
  • SHFS 0.10
  • Revenue
  • ALLK N/A
  • SHFS $15,658,629.00
  • Revenue This Year
  • ALLK N/A
  • SHFS N/A
  • Revenue Next Year
  • ALLK N/A
  • SHFS N/A
  • P/E Ratio
  • ALLK N/A
  • SHFS $3.65
  • Revenue Growth
  • ALLK N/A
  • SHFS 7.78
  • 52 Week Low
  • ALLK $0.23
  • SHFS $0.30
  • 52 Week High
  • ALLK $1.69
  • SHFS $1.01
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 33.29
  • SHFS 37.36
  • Support Level
  • ALLK $0.28
  • SHFS $0.38
  • Resistance Level
  • ALLK $0.33
  • SHFS $0.44
  • Average True Range (ATR)
  • ALLK 0.02
  • SHFS 0.03
  • MACD
  • ALLK 0.03
  • SHFS -0.01
  • Stochastic Oscillator
  • ALLK 55.70
  • SHFS 2.73

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

Share on Social Networks: